Potential interaction between clarithromycin and warfarin

Annals of Pharmacotherapy

Volumn 31, Issue 9, 1997, Pages 996-998

  Recker, Mark W ^a   Kier, Karen L ^b  

^a Lima Memorial Hospital   (United States)

^b OHIO NORTHERN UNIVERSITY   (United States)

Author keywords

Clarithromycin; Warfarin

Indexed keywords

AMLODIPINE; CLARITHROMYCIN; DIGOXIN; LEVOTHYROXINE; QUINIDINE GLUCONATE; RANITIDINE; SPIRONOLACTONE; VITAMIN K GROUP; WARFARIN;

AGED; ANGINA PECTORIS; ARTICLE; BLEEDING; BRONCHITIS; CASE REPORT; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; GLUCOSE INTOLERANCE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030852354     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100907     Document Type: Article

References (14)

1. Israel D, Polk R. Focus on clarithromycin and azithromycin: two new macrolide antibiotics. Hosp Form 1992;27:115-34.
2. Rodvold K, Piscitelli S. New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety. Clin Infect Dis 1993;17(suppl 1):192-9.
3. Kanatani M, Gugliemo B. The new macrolides: azithromycin and clarithromycin. West J Med 1994;160:31-7.
4. von Rosenstiel N, Adam D. Macrolide antibacterials, drug interactions of clinical significance. Drug Saf 1995;13:105-22.
5. Amsden GW. Macrolides versus azalides: a drug interaction update. Ann Pharmacother 1995;29:906-17.
6. Gillium J, Israel D, Polk R. Pharmacokinetic drug interactions with antimicrobial agents. Clin Pharmacokinet 1993;25:450-82.
7. Bachmann K, Schwartz J, Frogameni A, Jauregui L. The effect of erythromycin on the disposition kinetics of warfarin. Pharmacology 1984;28: 171-6.
8. Weibert R, McQuade Lorentz S, Townsend R, Cook C, Klauber M, Jagger P. Effect of erythromycin on patients receiving long-term warfarin therapy. Clin Pharm 1989;8:210-4.
9. Grau E, Esperanza R, Pastor E. Interaction between clarithromycin and oral anticoagulants (letter). Ann Pharmacother 1996;30:1495-6.
10. Slaughter RL, Edwards DJ. Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 1995;29:619-24.
11. Periti P, Mazzei T, Mini E, Novelli A. Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 1992;23:106-31.
12. Murray M. P450 enzymes: inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet 1992;23:132-46.
13. Package insert. Coumadin (warfarin). Wilmington, DE: DuPont Pharma, 1995.
14. Hirsch J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108(suppl):231S-46S.